Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002082246-25-000002
Filing Date
2025-08-19
Accepted
2025-08-19 17:19:13
Documents
6
Period of Report
2025-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1755638340.html 3  
1 FORM 3 wk-form3_1755638340.xml 3 2268
2 EX-24.WHEELER.POA wheeler_poa.htm EX-24.WHEELER.POA 6687
3 GRAPHIC wheeler_poa001.jpg GRAPHIC 194917
4 GRAPHIC wheeler_poa002.jpg GRAPHIC 83388
5 GRAPHIC wheeler_poa003.jpg GRAPHIC 64891
6 GRAPHIC wheeler_poa004.jpg GRAPHIC 22022
  Complete submission text file 0002082246-25-000002.txt   513755
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address
Wheeler Benjamin Richard (Reporting) CIK: 0002082246 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26642 | Film No.: 251232943